- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aelis Farma SA (AELIS)
Aelis Farma SA stock price live, this page displays EPA AELIS stock exchange data. View the AELIS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aelis Farma SA real time stock price chart below.
What Is the Aelis Farma SA Stock Price Today?
The Aelis Farma SA stock price today is 1.11.
What Is the Stock Symbol for Aelis Farma SA?
The stock symbol for Aelis Farma SA is "AELIS."
What Stock Exchange Does Aelis Farma SA Trade On?
Aelis Farma SA is listed and trades on the Paris stock exchange.
Is Aelis Farma SA a Good Stock to Buy?
Determining whether Aelis Farma SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AELIS quote. (ISIN: FR0014007ZB4)
What Is the Aelis Farma SA Stock Price Today?
The Aelis Farma SA stock price today is 1.11.
What Is the Stock Symbol for Aelis Farma SA?
The stock symbol for Aelis Farma SA is "AELIS."
What Stock Exchange Does Aelis Farma SA Trade On?
Aelis Farma SA is listed and trades on the Paris stock exchange.
Is Aelis Farma SA a Good Stock to Buy?
Determining whether Aelis Farma SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AELIS quote. (ISIN: FR0014007ZB4)
1.11
+0.09(+8.82%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.01
1.11
52 wk Range
0.95
2.30
AELIS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.011.11
52 wk Range
0.952.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AELIS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
11.00
Upside
+890.99%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.00
(+890.99% Upside)
Earnings
Latest Release
Apr 24, 2026
EPS / Forecast
-0.15 / --
Revenue / Forecast
1.19M / --
Compare AELIS to Peers and Sector
Metrics to compare | AELIS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAELISPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.2x | −3.4x | −0.3x | |
PEG Ratio | −0.14 | −0.09 | 0.00 | |
Price/Book | 3.1x | 1.1x | 2.6x | |
Price / LTM Sales | 6.7x | 25.1x | 3.1x | |
Upside (Analyst Target) | - | 152.6% | 48.3% | |
Fair Value Upside | Unlock | −0.8% | 6.7% | Unlock |
Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company owns a pipeline of pharmacological inhibitors, including AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; AEF0217, a drug candidate, which is in phase 1/2 clinical trials to treat cognitive deficits observed in down syndrome; and CB1-SSi, a new molecular entities to treat other CB1-dependent diseases, including several orphan diseases. Aelis Farma SA was incorporated in 2013 and is headquartered in Bordeaux, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Aelis Farma (AELIS) Stock Price Today?
The Aelis Farma stock price today is 1.11 EUR.
What Stock Exchange Does Aelis Farma Trade On?
Aelis Farma is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Aelis Farma?
The stock symbol for Aelis Farma is "AELIS."
What Is the Aelis Farma Market Cap?
As of today, Aelis Farma market cap is 15.09M EUR.
What Is Aelis Farma's Earnings Per Share (TTM)?
The Aelis Farma EPS (TTM) is -0.47.
From a Technical Analysis Perspective, Is AELIS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Aelis Farma Stock Split?
Aelis Farma has split 0 times.
How Many Employees Does Aelis Farma Have?
Aelis Farma has 16 employees.
What is the current trading status of Aelis Farma (AELIS)?
As of Aug 14, 2026, Aelis Farma (AELIS) is trading at a price of 1.11 EUR, with a previous close of 1.02 EUR. The stock has fluctuated within a day range of 1.01 EUR to 1.11 EUR, while its 52-week range spans from 0.95 EUR to 2.30 EUR.
What Is Aelis Farma (AELIS) Price Target According to Analysts?
The average 12-month price target for Aelis Farma is 11.00 EUR, with a high estimate of 11 EUR and a low estimate of 11 EUR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +890.99% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.